Health Products and Food Branch (HPFB) - Roadmap for 2007-2012

This content was archived on June 24, 2013.

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

---

1. About the Road Map
2. Strategic Plan 2007-2012 - Commitments
3. Blueprint for Renewal II
4. Strategic Plan 2004-2007- Achievements

1. About the Road Map

The purpose of the Roadmap is to provide an overview of key Health Products and Food Branch (HPFB) strategic frameworks: the 2007-2012 Strategic Plan, the Blueprint for Renewal and the 2004-2007 Strategic Plan.

In the sections below you will find the strategies and commitments laid out in the current plan and a review of the achievements that stemmed from the 2004-2007 Strategic Plan. For further information see the Blueprint for Renewal main page.

2. Strategic Plan 2007-2012 - Commitments

Launched in April 2007, the HPFB 2007-2012 Strategic Plan lays out six main strategies, and lists a number of commitments which will contribute to the implementation of each strategy. These strategies and commitments, as well as the timeline for each commitment, are listed in the table below.

Strategy	Commitment Timeline	commitment
Strategy 1: Adopt a lifecycle approach to regulating health products	2007-2008	Review of the Special Access Program (sap) Review of the Clinical Trials Regulatory Framework Develop and implement new regulatory frameworks for vaccines, radiopharmaceuticals, cells, tissues and organs, and blood
	2007-2010	Natural Health Products regulatory review Implement a new compliance and enforcement strategy for health products Establish clear and consistent product categorization regime Strengthen regulatory foresight and scientific advice to sponsors
	2007-2012	Establish and implement Progressive Licensing Framework (PLF) for pharmaceuticals and biologics Implement post-market surveillance strategy Strengthen leadership on issues related to specific populations
Strategy 2: Promote health through a modernized food regulatory system and a proactive approach to nutrition	2007-2008	Develop and implement new regulatory frameworks for food related health claims
	2007-2010	Develop and implement regulatory modernization strategy for food and nutrition Implement the food borne contaminants initiative for the Government's Chemical Management Plan
Strategy 3: Advance international co-operation and be an International leader	2007-2012	Engage in international co-operation, harmonization and worksharing
Strategy 4: Establish strategic partnerships to fulfill our mandate	2007-2008	Develop and implement Science Plan 2007-2012
Strategy 5: Better integrate transparency, openness and accountability into our day-to-day work	2007-2008	Implement policy on Public Input in the review of health products Registration and disclosure of Clinical Trials
Strategy 6: Build a nationally-based, flexible organization that can fulfil its mandate and priorities in a changing environment	2007-2010	Establish new electronic review systems for the branch Support Health Canada legislative renewal initiative

3. Blueprint for Renewal II

The revised Blueprint for Renewal II builds on the original policy framework of the first document and offers more comprehensive and detailed plans related to the implementation of the various objectives and initiatives. It focuses on the full range of legislative, regulatory and policy issues needed to modernize our approach to health products and food. For detailed information on the Blueprint, see the Blueprint for Renewal main page.

4. Strategic Plan 2004-2007 - Achievements

Launched in April 2004, the HPFB 2004-2007 Strategic Plan laid out five key strategies, with key results and performance indicators. The achievements stemming from each of these strategies are outlined in the table below.

Strategy	Year(s) Achieved	Achievement
Strategy 1: Transforming branch efficiency, effectiveness and responsiveness as a regulator	2004-2007	Cleared submission backlogs for pharmaceuticals and biologics and medical devices and met performance review targets Implemented Natural Health Products regulations Expanded cooperation with international regulatory authorities
	2006-2007	Developed cells, tissues an organs regulations Launched and consulted on Blueprint for Renewal
Strategy 2: Providing authoritative information for healthy choices and informed decisions by Canadians	2004-2007	Developed new Product Monograph template
	2005-2006	Implemented nutrition labelling regulations Launched MedEffect website
	2006-2007	Published the revised Canada 's Food Guide
Strategy 3: Increasing responsiveness to public health issues and vigilance over safety and therapeutic effectiveness	2004-2007	Strengthened post-market surveillance and compliance and enforcement Strengthened Clinical Trials oversight
	2005-2006	Established the Office of Pediatric Initiatives Establishment of two new regional adverse drug reactions monitoring offices
	2006-2007	Supported Trans-Fats Taskforce Launched Food-Borne Contaminants Initiative
Strategy 4: Improving transparency, openness and accountability to strengthen public trust and stakeholder relationships	2004-2007	Published series of reports outlining Branch plans and performance Regularly published Summary Basis of Regulatory Decisions
	2005-2006	Conducted two groundbreaking public forums on COX-2 and silicone gel-filled breast implants Developed Public Involvement Framework
	2006-2007	Consulted and implemented policy on public input in the review of health products
Strategy 5: A nationally- based, flexible organization that has the capacity to fulfill its mandate and priorities in a changing environment	2004-2007	Developed new technologies to support e-review of product submissions
	2005-2006	Implemented Branch Audit and Evaluation Office
	2006-2007	Created and staffed Branch Science Advisor position and Office of Science and Risk